These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15567626)

  • 1. The diagnostic randomized clinical trial is the best solution for management issues in critical limb ischemia.
    de Graaff JC; Ubbink DT; Tijssen JG; Legemate DA
    J Clin Epidemiol; 2004 Nov; 57(11):1111-8. PubMed ID: 15567626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
    Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
    Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of toe pressure and transcutaneous oxygen measurements in management of chronic critical leg ischemia: a diagnostic randomized clinical trial.
    de Graaff JC; Ubbink DT; Legemate DA; Tijssen JG; Jacobs MJ
    J Vasc Surg; 2003 Sep; 38(3):528-34. PubMed ID: 12947272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
    de Donato G; Gussoni G; de Donato G
    Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia.
    Melillo E; Ferrari M; Balbarini A; Pedrinelli R
    Vasc Endovascular Surg; 2006; 40(4):303-11. PubMed ID: 16959724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation.
    Nizankowski R; Petriczek T; Skotnicki A; Szczeklik A
    Kardiol Pol; 2005 Oct; 63(4):351-60; discussion 361. PubMed ID: 16273471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progenitor cell therapy in patients with critical limb ischemia without surgical options.
    Sprengers RW; Lips DJ; Moll FL; Verhaar MC
    Ann Surg; 2008 Mar; 247(3):411-20. PubMed ID: 18376183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ischemic wounds with noncontact, low-frequency ultrasound: the Mayo clinic experience, 2004-2006.
    Kavros SJ; Miller JL; Hanna SW
    Adv Skin Wound Care; 2007 Apr; 20(4):221-6. PubMed ID: 17415030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
    Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
    Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design and interpretation of pilot trials in clinical research in critical care.
    Arnold DM; Burns KE; Adhikari NK; Kho ME; Meade MO; Cook DJ;
    Crit Care Med; 2009 Jan; 37(1 Suppl):S69-74. PubMed ID: 19104228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors for critical limb ischemia after autologous bone marrow implantation].
    Oda M; Kato K; Toba K; Otaki K; Kitajima T; Ikarashi N; Yanagawa T; Higashimura M; Asami F; Isoda M; Ozawa T; Moriyama M; Hirono S; Okura Y; Hanawa H; Kodama M; Aizawa Y
    J Cardiol; 2007 Oct; 50(4):235-42. PubMed ID: 17987839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.
    Gu YQ; Zhang J; Guo LR; Qi LX; Zhang SW; Xu J; Li JX; Luo T; Ji BX; Li XF; Yu HX; Cui SJ; Wang ZG
    Chin Med J (Engl); 2008 Jun; 121(11):963-7. PubMed ID: 18706241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better conduct of clinical trials: the control group in critical care trials.
    Takala J
    Crit Care Med; 2009 Jan; 37(1 Suppl):S80-90. PubMed ID: 19104230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utilization of transcutaneous oxygen pressures to guide decision-making for spinal cord stimulation implantation for inoperable peripheral vascular disease: a report of two cases.
    Provenzano DA; Jarzabek G; Georgevich P
    Pain Physician; 2008; 11(6):909-16. PubMed ID: 19057636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Types of clinical studies. IV. Clinical trials.
    Roque A; Carneiro AV
    Rev Port Cardiol; 2005 Dec; 24(12):1539-56. PubMed ID: 16566410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemospan: a hemoglobin-based oxygen carrier for potential use as a blood substitute and for the potential treatment of critical limb ischemia.
    Smani Y
    Curr Opin Investig Drugs; 2008 Sep; 9(9):1009-19. PubMed ID: 18729008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.